Summary score of STARD items
| Item | Yes | Partial* | No | NA† | |
|---|---|---|---|---|---|
| *Item 6. Two publications did not mention whether the design was prospective or retrospective but in the text mentioned that the patients were consented for the study. | |||||
| Item 8. Three studies only cited a reference for technical details of either the index or the reference test. | |||||
| Item 9. Four articles described units and/or cut-off points but no rationale and were considered to partially fulfil this item. For example one study (table 2 no 7) classified glaucoma severity on the basis of mean deviations (MD) without providing any rationale or reference. | |||||
| Item 11. Described that some information was provided to the investigators, although it was not known whether the investigators were masked or not | |||||
| †Item 16. This item was classified as “not applicable” in a retrospective study that only included patients who had both the index and reference tests done (table 2 no 5). | |||||
| Item 17. This item was classified as “not applicable” in a retrospective study in which frozen histopathological samples were re-analysed with a new diagnostic test (table 2 no 6) | |||||
| Item 20. Reporting of adverse events was marked as “not applicable” because of the non-invasive nature and safety profile of the tests. | |||||
| Title, abstract, and keywords | 1 | 8 | 0 | 8 | 0 |
| Introduction | 2 | 16 | 0 | 0 | 0 |
| Methods | |||||
| Participants | 3 | 13 | 3 | 0 | 0 |
| 4 | 13 | 0 | 3 | 0 | |
| 5 | 8 | 0 | 8 | 0 | |
| 6 | 13 | 2* | 1 | 0 | |
| Test methods | 7 | 5 | 6 | 5 | 0 |
| 8 | 11 | 3* | 2 | 0 | |
| 9 | 8 | 4* | 4 | 0 | |
| 10 | 6 | 4 | 6 | 0 | |
| 11 | 6 | 1* | 9 | 0 | |
| Statistical methods | 12 | 14 | 0 | 2 | 0 |
| 13 | 2 | 0 | 14 | 0 | |
| Results | |||||
| Participants | 14 | 6 | 0 | 10 | 0 |
| 15 | 12 | 0 | 4 | 0 | |
| 16 | 4 | 0 | 11 | 1† | |
| Test results | 17 | 9 | 0 | 6 | 1† |
| 18 | 10 | 1 | 5 | 0 | |
| 19 | 7 | 3 | 6 | 0 | |
| 20 | 0 | 0 | 0 | 16† | |
| Estimates | 21 | 4 | 12 | 0 | 0 |
| 22 | 5 | 0 | 11 | 0 | |
| 23 | 4 | 0 | 12 | 0 | |
| 24 | 1 | 0 | 15 | 0 | |
| Discussion | 25 | 16 | 0 | 0 | 0 |
| Flow diagram | 1 | ||||









